INM 2.10 ▼ -2.78% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.10
    -0.06 (-2.78%)
    At close: Sep 12, 2025, 3:59 PM
    2.19
    4.29%
    After-hours: Sep 12, 2025, 05:36 PM EDT
    -2.78%
    Bid 2.06
    Market Cap 4.2M
    Revenue (ttm) 6.87M
    Net Income (ttm) -11.65M
    EPS (ttm) -11.65
    PE Ratio (ttm) -0.18
    Forward PE n/a
    Analyst n/a
    Ask 2.29
    Volume 89,555
    Avg. Volume (20D) 1,898,358
    Open 2.16
    Previous Close 2.16
    Day's Range 2.10 - 2.28
    52-Week Range 1.72 - 8.27
    Beta 0.41

    About INM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol INM
    Website n/a
    Full Company Profile
    2 months ago
    +57.96%
    InMed shares are trading higher after the company ... Unlock content with Pro Subscription
    7 months ago
    +2.02%
    InMed Pharmaceuticals shares are trading higher after the company announced that INM-901 reduced Alzheimer 's-related inflammation in a preclinical study.
    news image

    1 week ago · newsfilecorp.com

    InMed to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

    Vancouver, British Columbia--(Newsfile Corp. - September 5, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of pr...

    news image

    1 month ago · newsfilecorp.com

    InMed to Present INM-901 Data at Alzheimer's Association International Conference (AAIC) 2025

    Long-term INM-901 treatment in preclinical studies in advanced disease continues to show multi-modal activity Vancouver, British Columbia--(Newsfile Corp. - July 28, 2025) - InMed Pharmaceuticals Inc....

    news image

    2 months ago · newsfilecorp.com

    InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

    Vancouver, British Columbia--(Newsfile Corp. - June 27, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    news image

    2 months ago · newsfilecorp.com

    InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

    Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    news image

    2 months ago · newsfilecorp.com

    InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

    Demonstrates statistically significant reduction of pro-inflammatory cytokines, including IL-6, IL-1β, IL-2, and KC/Gro Significantly reduces levels of inflammasome marker, NLRP3, a key contributor to...

    news image

    3 months ago · newsfilecorp.com

    InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA

    Vancouver, British Columbia--(Newsfile Corp. - June 13, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of propri...

    Add to Watchlist